FDA Takes Further Steps to Confront Opioid Crisis Through Risk Evaluation and Mitigation Strategy Programs ...Middle East

Washington, D.C…. While our efforts to combat COVID-19 remain at the forefront of our day-to-day activities, the U.S. Food and Drug Administration also continues its work on a number of important public health issues and, in particular, the opioid crisis. We remain committed to using all facets of our regulatory authority to lessen the impact of opioid addiction, misuse, and abuse while also striking a careful balance between patient access and safety to ensure that patients suffering from significant pain have access to appropriate medication. To that end, the FDA has been and continues to address this public health crisis on a number of fronts, including efforts to: Decrease unnecessary

Hence then, the article about fda takes further steps to confront opioid crisis through risk evaluation and mitigation strategy programs was published today ( Sunday 27/12/2020 - 02:15 PM ) and is available on Thepintree.net ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Takes Further Steps to Confront Opioid Crisis Through Risk Evaluation and Mitigation Strategy Programs )

Also on site :

• North Korean operatives stole $2 billion last year—and financial firms are the next target
• Nepal in a bind as US-China drone war reaches Everest
• Polestar CEO tells CNBC ‘pump anxiety’ has made EVs ‘all about money’